Aprinoia Therapeutics Inc APRI
Trading Information
- Previous Close Price
- —
- Day Range
- —–—
- 52-Week Range
- —–—
- Bid/Ask
- — / —
- Market Cap
- —
- Volume/Avg
- — / —
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- —
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Aprinoia Therapeutics Inc is a clinical-stage biotechnology company. It is engaged in protecting patients’ brain health and changing clinical outcomes for a broad range of neurodegenerative diseases by developing novel, highly sensitive and selective diagnostic tools and novel therapeutics. Neurodegenerative diseases are relentless and largely fatal, resulting from progressive loss of nerve cells in the brain and, depending on the specific disorders, can affect a broad range of cognitive, behavioral, and motor functions, such as memory, thinking, speaking, walking, and breathing. It is developing several different diagnostic and therapeutic platforms such as abnormal protein aggregates of tau and alpha synuclein (“α-Syn”) that are toxic to brain cells.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- —
- Total Number of Employees
- —
- Website
- https://www.aprinoia.com
Valuation
|
Metric
|
APRI
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | — |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
APRI
|
|---|---|
Quick Ratio | 0.27 |
Current Ratio | 0.31 |
Interest Coverage | −13.47 |
Quick Ratio
APRI
Profitability
|
Metric
|
APRI
|
|---|---|
Return on Assets (Normalized) | −190.99% |
Return on Equity (Normalized) | — |
Return on Invested Capital (Normalized) | — |
Return on Assets
APRI
Biotechnology Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
NVO
| Novo Nordisk A/S ADR | Gjfbnddgjr | Rvhnr | $553.3 Bil | |
VRTX
| Vertex Pharmaceuticals Inc | Cnmsfmzyx | Lcmhwq | $101.6 Bil | |
REGN
| Regeneron Pharmaceuticals Inc | Xmtzjjd | Jdvgzgt | $98.9 Bil | |
MRNA
| Moderna Inc | Yrpjlpj | Ysrr | $39.7 Bil | |
ARGX
| argenx SE ADR | Yhrnpgc | Bsytn | $21.5 Bil | |
BNTX
| BioNTech SE ADR | Kddflsrfk | Vmwby | $20.8 Bil | |
ALNY
| Alnylam Pharmaceuticals Inc | Tgqctrtpz | Mmdyrym | $18.4 Bil | |
BMRN
| Biomarin Pharmaceutical Inc | Dhlrjzczj | Rdfssf | $17.2 Bil | |
RPRX
| Royalty Pharma PLC Class A | Nyzyvqwby | Lksdc | $12.3 Bil | |
INCY
| Incyte Corp | Knbdjbsr | Jjlhjhp | $11.8 Bil |